The Globe and Mail reports in its Friday, Nov. 14, edition that RBC Capital analyst Andrew Wong has reaffirmed his "outperform" recommendation for Cameco. The Globe's David Leeder writes in the Eye On Equities column that Mr. Wong gave his share target a $10 trim to $150. Analysts on average target the shares at $145.58. Mr. Wong says in a note: "Our visit to the Vogtle three and four nuclear reactors in Georgia, hosted by Cameco and Southern Company, helped us gain an appreciation for the advancements incorporated into the Westinghouse AP1000 design. We also came away with a better understanding of the learning from the Vogtle three and four builds, which can be applied to a future build out of the AP1000 design. We see the Westinghouse AP1000 reactor at the forefront of designs to be widely deployed in the U.S. and Western-aligned countries, and view Cameco as best-positioned in a growing nuclear industry given exposure across the nuclear value chain." The Globe reported on July 31 that Canaccord had reaffirmed its "buy" ranking for Cameco. It was then worth $104.03. The Globe reported on Aug. 1 that Mr. Wong had reaffirmed his "outperform" recommendation for Cameco. The shares could then be had for $100.63.